Philip Brandish

Philip Brandish

Company: Merck

Job title: Senior Principal Scientist


Phil Brandish trained in chemistry and biochemistry and has almost 20 years of experience in drug R&D and has focused now for several years on cancer immunotherapy. Phil leads a team of immunologists and cell biologists at Merck Research Labs in Boston focused on myeloid and fibroblast biology for the treatment of cancer. Phil serves as co-lead for several early clinical stage immuno-oncology programs as well as subject matter expert for partnership and licensing opportunities. 


Therapeutic Approaches & Basic Research on Myeloid Immune Suppression in the Tumor Microenvironment 3:30 pm

• Analyze the evidence for myeloid cell infiltrates limiting clinical responses • Discuss the types and mechanisms of myeloid immune suppression in the TME • Outline emerging therapeutic approaches and basic researchRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.